During the past decade, Anderson Clinical Research conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 20 clinical trials were completed, i.e. on average, 64.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 15 clinical trials were completed. i.e. 107.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Anderson Clinical Research" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Biogen" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anderson Clinical Research" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator and "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Anderson Clinical Research" are "Alzheimer's Disease" (11 trials), "HIV Infections" (8 trials), "Depressive Disorder, Major" (5 trials), "Migraine" (5 trials) and "Alzheimer Disease" (4 trials). Many other conditions were trialed in "Anderson Clinical Research" in a lesser frequency.

Most popular intervention types in "Anderson Clinical Research" are "Drug" (48 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Crenezumab" (3 trials), "Didanosine" (3 trials), "Galcanezumab" (3 trials) and "Rapastinel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Anderson Clinical Research" are 49 trials for "All" genders.

Currently, there are NaN active trials in "Anderson Clinical Research". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 29 completed trials in Anderson Clinical Research, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Anderson Clinical Research, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".